In agreement with the results obtained in mice demonstrating how sortilin signaling alters sphingolipid metabolism, thereby promoting endothelial dysfunction and arterial hypertension, our data in humans suggest that sortilin and its mediators may represent new biomarkers for the prediction of vascular dysfunction and high BP. The gene discussed is SORT1; the disease is Hypertension.